Strs Ohio Surface Oncology, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$2.65 - $5.08 $353,775 - $678,180	-133,500 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$4.73 - $7.9 $56,287 - $94,010	11,900 Added 9.79%	133,500 $638,000
Q3 2021 Oct 22, 2021	BUY	$5.16 - $7.98 $70,176 - $108,528	13,600 Added 12.59%	121,600 $920,000
Q2 2021 Jul 26, 2021	BUY	$6.45 - $9.09 $696,600 - $981,720	108,000 New	108,000 $805,000
Q3 2019 Oct 21, 2019	SELL	$1.4 - $2.84 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$2.75 - $4.89 $89,100 - $158,436	-32,400 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$3.65 - $10.69 $64,970 - $190,282	17,800 Added 121.92%	32,400 $137,000
Q3 2018 Oct 19, 2018	BUY	$8.92 - $17.83 $111,500 - $222,874	12,500 Added 595.24%	14,600 $159,000
Q2 2018 Aug 06, 2018	BUY	$12.83 - $17.41 $26,943 - $36,561	2,100 New	2,100 $34,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.